Search Results 191-200 of 3082 for Mão Morta de Volkmann
Patients enrolled in the lead-in phase of this study are required to have relapsed following a prior autologous or allogeneic HSCT, or to be ineligible for HSCT ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell transplant ...
About this study. This is a prospective, randomized, controlled, unblinded, multi-center evaluation of the stroke incidence in patients implanted with a ...
Principal Investigator: Chunfeng Zhao, M.D.. Project Coordinator: Chunfeng Zhao, M.D. — zhao.chunfeng@mayo.edu. Funding Source: Musculoskeletal Transplant ...
Nivolumab works through the body's immune system to help the immune system act against tumor cells. Chemotherapy drugs, such as paclitaxel, work in different ...
This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against ...
The human brain possesses unique blood vessels designed to maintain a constant supply of blood to highly perfused neuronal tissue. Impairment of brain blood ...
This study is designed to identify genes shared between humans with hypertrophic cardiomyopathy and rhesus macaque primates who have experienced sudden cardiac ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.